Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Swiss Biotech IPOs May Revive Industry Starved of Investment
Swiss Biotech IPOs May Revive Industry Starved of Investment
Swiss Biotech IPOs May Revive Industry Starved of Investment
Submitted by
admin
on July 7, 2011 - 10:15pm
Source:
Bloomberg
News Tags:
IPOs
Roche
Novartis
Actelion
Molecular Partners
Newron Pharma
Switzerland
Headline:
Swiss Biotech IPOs May Revive Industry Starved of Investment
Do Not Allow Advertisers to Use My Personal information
